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Abstract
Background: Female sex workers (FSWs) are amongst the most susceptible groups to acquire human
papillomavirus (HPV) infection and consequently, to develop cervical intraepithelial neoplasia and cervical cancer.
This is the first systematic review and meta-analysis to provide estimates of the pooled prevalence of HPV infection
and the distribution of HPV types among FSWs across the world.
Methods: Five computerized databases were searched for relevant studies published since the inception date of
databases to September 2019. The pooled HPV prevalence was calculated by the random effect model described
by DerSimonian-Laird. Subgroup analysis was performed to identify the probable sources of heterogeneity. The
meta-analysis was performed using the “Metaprop” function in the R package Meta.
Results: Sixty-two studies involving 21,402 FSWs from 33 countries were included in this meta-analysis, and the
pooled HPV prevalence was 42.6% (95% confidence interval (CI): 38.5–46.7%). HPV-16 (10.1, 95% CI: 8.2–12.5%), HPV-
52 (7.9, 95% CI: 5.9–10.7%), and HPV-53 (6.0, 95% CI: 4.4–8.1%) were the most common high-risk HPV types
identified among FSWs. The pooled estimated prevalence of HPV infection among FSWs before and after 2010
were slightly different, 43.6% (95% CI: 36.1–51.4%) and 41.9% (95% CI: 37.2–46.8%), respectively.
Conclusion: Due to the high prevalence of HPV infection, particularly with high-risk types, FSWs have a great
susceptibility to the development of cervical and vaginal cancers. Furthermore, they can transmit their infection to
their clients, which may result in a high prevalence of HPV and the incidence of HPV-associated malignancies
among the general population.
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Background
Human papillomavirus (HPV) is the most frequently
sexually transmitted pathogen in humans. There are
more than 200 different HPV genotypes recognized to
date which are classified into two major groups, high-
risk and low-risk genotypes in terms of their
malignancy-causing potential [1, 2]. HPV types 6 and
11 are known to be responsible for 90% of genital
warts, and types 16 and 18 together cause up to 70%
of invasive cervical cancer worldwide. Along with cer-
vical cancer, HPV types 16 and 18 are responsible for
40–50% of invasive vulvar cancer and 70% of vaginal
cancer [3]. HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56,
58, 59, 66, 68, 73 and 82 are considered high risk ge-
notypes, whereas low-risk genotypes include HPV-6,
11, 34, 40, 42, 43, 44, 54, 61, 70, 72, 81, and 89 [4].
There are three available HPV vaccines licensed by
the U.S. Food and Drug Administration (FDA):
quadrivalent HPV vaccine, including HPV types 6, 11,
16, and 18 (Gardasil®, produced by Merck); bivalent
HPV vaccine, including HPV types 16 and 18 (Cer-
varix™, produced by GlaxoSmithKline), and nine-
valent vaccine, including HPV types 6, 11, 16, 18, 31,
33, 45, 52 and 58 (Gardasil 9; produced by Merck) [5,
6]. Previous reports suggested that 65–100% of the
sexually active population are exposed to HPV during
their lifespan [7]. Men who have sex with men
(MSM) as a sexually active group have a high preva-
lence of HPV infection (81 and 47% among HIV-
positive and HIV-negative MSM, respectively) [8].
The HPV prevalence among women from the general
population seems to be lower so that Sabeena et al.
have reported the pooled HPV prevalence of 11%
among women attending cervical cancer screening
clinics [9].
Cervical cancer is the fourth most frequent type of
gynecological cancer worldwide, with a high mortality
rate. More than 270,000 women annually die from
cervical cancer worldwide, which most of them (~
85%) are in developing countries [10, 11]. Almost all
cases of cervical cancer are caused by persistent HPV
infection, which is usually transmitted by sexual inter-
course. Accordingly, cervical cancer is more common
among females with multiple sex partners [12]. In a
study conducted by Liu et al., the association between
the number of sexual partners and the risk of cervical
cancer was assessed through a meta-analysis [13].
Their results suggested that the number of sexual
partners was related to the development of cervical
cancer.
Female sex workers (FSWs) are a group of females
who provide sexual services for economic remuner-
ation [14]. They are a heterogeneous population
group who work in varied work environments and
community organizations. Street-based sex workers
are mainly illegal workers who solicit clients on the
street or in public settings such as markets, parks,
cinema halls, and service them in alleys, or the cli-
ents’ cars. Another group is indoor-based sex
workers who are employed to work in brothels, ho-
tels, massage parlors, saunas, and lodges. In some
cases, they might solicit clients independently based
on both on-street and off-street, by online advertis-
ing in newspapers or by phone or text, or might
work for a pimp or manager [15–17]. FSWs are at
greatly elevated risk of acquiring sexually transmitted
infections (STIs), including HPV, and their clients
can act as a bridging population toward the general
population. The major underlying risk factors for
this high-risk group include multiple sex partners
[14, 18], unsafe sex behaviors [19, 20], earlier age of
sex work debut [21, 22], the years of engaging in sex
work [23], and low educational status [24]. It is be-
lieved that sexual contact with FSWs contributes to
HPV transmission and leads to a high prevalence of
cervical cancer in this population [24]. Besides, they
elevate the risk of penile cancer in males by the
spread of the virus to their male clients [24, 25].
Previous studies have been reported that FSWs have
more than two times the probability of having HPV
infection compared with women from the general
population and have an increased prevalence of ab-
normal pap smears [26, 27]. It has been reported
that FSWs have significantly more cytological abnor-
malities such as atypical squamous cells of undeter-
mined significance (ASCUS) than women from the
normal population. Following abnormal cytology and
HPV infection, the occurrence of cervical intrae-
pithelial neoplasia (CIN) 1, CIN 2, or CIN 3 was sig-
nificantly higher among FSWs compared to the
general population [28]. Thus, FSWs are thought to
be at elevated risk of cervical dysplasia development
due to the high HPV exposure [24, 28, 29].
There are a few review publications focused on the
prevalence of HPV infection in the FSW population
worldwide. Soohoo et al. reviewed articles assessing
the prevalence of HPV types among FSWs in the
world [30]. Based on 35 peer-reviewed publications
included in their review, the median overall HPV
prevalence was 42.7%, with a range of 2.3 to 100%.
The ten most common HPV types were HPV-6
(11.5%), 16 (38.9%), 18 (23.1%), 31 (28.4%), 33
(25.0%), 39 (21.6%), 51 (25.0%), 52 (32.7%), 56 (24.0%)
and 58 (26.0%). In another study conducted by Peng
et al. in 2010, a meta-analytic approach was used to
estimate the prevalence and genotype distribution of
cervical HPV infection among FSWs in Asia [31].
They found that crude estimates of the cervical
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prevalence of HPV among 4198 Asian FSWs ranged
from 12.8 to 84.8%. According to their results, HPV
prevalence among FSWs was nearly 10 times higher
than that of the general population of women.
Regarding the important role of HPV infection in
the development of cervical cancer and other associ-
ated diseases, numerous studies have investigated the
prevalence and the distribution of HPV types within
FSWs. However, there is not a systematic review and
meta-analysis to estimate the overall pooled preva-
lence of HPV infection in this high-risk population.
To the best of our knowledge, this is the first system-
atic review and meta-analysis that characterizes the
global epidemiology of HPV infection and the distri-
bution of high-risk and low-risk HPV types among
FSWs. Our study will provide a comprehensive pic-
ture of the health status of women engaged in sex
trading in the aspect of HPV infection, as one of the
major sexually transmitted diseases. The high preva-
lence of HPV infection among FSWs will persuade
policy-makers to promote strategies such as cervical
screening and HPV vaccination to reduce the inci-
dence of cervical cancer in this population.
Methods
This systematic review and meta-analysis was based on
the items outlined in the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guide-
line [32].
Search strategy
We conducted an electronic literature search using Web
of Science, Scopus, PubMed, Embase, and Google
scholar from database inception to September 2019 to
identify eligible publications. The details of the search
terms for each database are presented in Additional file
1. Moreover, reference lists of all articles included were
scanned by hand to find additional eligible studies. All
identified records were imported to EndNote software
version X8 (Thomson Reuters, California, USA) for fur-
ther management.
Selection criteria
In our study, FSWs are defined as women who offer
sexual services in return for money, goods, or other
markers of economic remuneration. Studies were con-
sidered eligible for inclusion if they reported: (1) ori-
ginal data about the prevalence measure for HPV
infection among FSWs published in the English lan-
guage in peer-reviewed journals; (2) the prevalence of
HPV DNA in different genital specimens, including
cervical, endocervical, vaginal, and cervico-vaginal
samples; (3) Studies detecting HPV DNA and tran-
scripts with polymerase chain reaction (PCR),
Hybridization, PCR-Hybridization, and Transcription-
mediated amplification (TMA) methods; (4) letters to
the editor, short communications, and English ab-
stracts with sufficient data. Studies meeting any of
the following criteria were excluded: (1) studies esti-
mating the incidence of HPV infection among FSWs;
(2) studies of the incidence and the prevalence of
HPV infection among transgenders, male sex workers,
gays, lesbians, and clients of FSWs; (3) Serological
studies that measured antibodies to HPV using
methods such as enzyme-linked immunosorbent assay
(ELISA); (4) review articles, case reports, posters, and
conference abstracts; (5) articles in languages other
than English with non-English abstracts.
Data extraction and quality assessment
Two investigators independently reviewed the eligible
articles and extracted data, including the first author’s
last name, publication year, study location, total sam-
ple size, type of specimen, diagnostic methods, diag-
nostic indexes, number of HPV-positive cases, and
types of HPV. The extracted data were imported into
an Excel spreadsheet (Microsoft Corporation, Red-
mond, WA, USA), and any discrepancies were re-
solved by a third investigator. A quality assessment of
the retrieved studies was performed according to a
modified checklist based on the guidelines of the
strengthening the reporting of observational studies in
epidemiology (STROBE) [33, 34]. The checklist was
comprised of 12 questions covering different meth-
odological perspectives. Studies were deemed eligible
for the main meta-analysis if they achieved a validity
score of at least 8 out of a maximum of 12.
Statistical analysis
To measure the pooled prevalence of HPV infection
among FSWs, a DerSimonian-Laird random-effects
meta-analysis was performed [35]. The method is based
on the inverse-variance approach, making an adjustment
to the study weights dependent on the amount of vari-
ation, or heterogeneity, among the different intervention
effects. The results of the random-effects and the
fixed-effect methods will be identical when there is
no heterogeneity between the studies. Where hetero-
geneity is present, confidence intervals (CIs) around
the random-effects summary estimates are wider than
CIs around the fixed-effect summary estimates and
corresponding claims of statistical significance will be
more conservative [36].
To stabilize the variance and normalize their distribu-
tion, the logit transformation was used, and the
Clopper-Pearson method was applied to estimate the
95% exact CIs for proportions [37]. To explore the pos-
sible sources of heterogeneity, subgroup analyses were
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performed based on study location, type of specimen,
diagnostic method, and diagnostic index. To assess
the heterogeneity across the included studies, the I2
statistic was employed, in which the result is
expressed as a percentage [38]. Jackson’s method was
used for the estimation of the confidence interval of
tau^2 and tau [39]. The meta-analysis was performed
using the “Metaprop” function in the R package
“meta” [40] (version 3.5.3 [2019-03-11], R Foundation
for Statistical Computing, Vienna, Austria). For all
statistical tests, differences with P values of < 0.05
were considered statistically significant. Graph of the
prevalence and genotype distribution of genital HPV
was drawn using GraphPad Prism 7.1 for Windows
(GraphPad Software, La Jolla California USA).
Results
Literature search
In the initial literature review, 810 articles were iden-
tified through searching the five electronic inter-
national databases. Also, 4 relevant articles were
found and included by a manual search of the refer-
ence lists of the identified articles. A total of 402 du-
plicates was excluded, and then 412 articles were
reviewed by title and abstract, which led to the elim-
ination of 269 articles. The remaining 143 articles
were checked for eligibility by the full-text review.
After the full-text screening, 77 articles were excluded
based on the inclusion/exclusion criteria. Based on
the modified STROBE checklist, 62 papers were con-
sidered to have good quality (obtained scores of 8
and above), and 4 papers were failed to reach score 8.
Overall, 62 articles were included in this systematic
review and meta-analysis. Figure 1 shows the process
of literature retrieval and screening using a flow
diagram.
Study characteristics
The characteristics of eligible studies in this system-
atic review and meta-analysis are summarized in
Table 1. Sixty-two studies with a total of 21,402
FSWs were included in this meta-analysis. The stud-
ies’ publication dates ranged from 1992 to 2019, and
they examined the population of 33 countries. The
largest study included 2308 and the smallest included
34 FSWs. Most studies investigating the prevalence of
HPV infection were from Kenya (n = 7) and China
(n = 4). Out of 62 included studies, 35 assessed the
genotype distribution of HPV among FSWs. In one
study [57], researchers were investigated the preva-
lence of only one type of HPV (HPV-16) among
FSWs. Therefore, we excluded this study from the
main meta-analysis calculating the pooled prevalence
to avoid underestimating, and the results of genotype
distribution were just included for the analysis. In
total, 39.3% of the studies (n = 24) were performed
before 2010, and 60.7% of the studies (n = 37) were
performed after 2010.
Prevalence of genital HPV infection among FSWs
Our current study aimed to determine the pooled preva-
lence of HPV infection in 21,179 FSWs from 32 coun-
tries, and the range was from 5.5 to 84.7% of the
selected individual studies. Figure 2 shows the preva-
lence of HPV and 95% CI estimates from individual
studies according to the random-effects model. The
pooled prevalence of HPV infection among FSWs was
42.6% (95% CI: 38.5–46.7%).
We divided the individual studies into two time pe-
riods of publication, before and after 2010. The polled
estimated prevalence of HPV infection among FSWs be-
fore and after 2010 were slightly different, 43.6% (95%
CI: 36.1–51.4%) and 41.9% (95% CI: 37.2–46.8%), re-
spectively (Fig. 2). However, the difference was not sta-
tistically significant (P = 0.71). Among studies performed
after 2010, the maximum and minimum prevalence of
HPV infection among FSWs were found in Hungary and
Mexico, respectively (82.3, 95%CI: 65.9–91.8% vs 5.5,
95%CI: 3.5–8.7%). The most frequent HPV types de-
tected in Mexico were HPV-73 (5.8, 95%CI: 4.1–8.3%),
HPV-39 (5.6, 95%CI: 3.9–8.0%), and HPV-54 (5.2,
95%CI: 3.6–7.6%), while the only one study performed
in Hungary [60] did not perform any analysis for HPV
typing.
For studies with HPV DNA detection in genital sam-
ples of FSWs, there was statistically significant difference
between the prevalence of HPV using vaginal (68.4, 95%
CI: 37.7–88.5%), cervical (41.9, 95% CI: 37.6–46.4%),
cervico-vaginal (46.2, 95% CI: 40.2–52.2%), and endocer-
vical (31.1, 95% CI: 21.1–43.4%) specimens (P = 0.04).
Concerning HPV detection methods in genital samples
of FSWs, PCR, hybridization, PCR-hybridization, and
TMA (transcription-mediated amplification) methods
were used. The prevalence of HPV was 43.2% (95% CI:
37.8–48.8%), 41.4% (95% CI: 32.4–51.1%), 40.9% (95%
CI: 37.7–44.2%), and 31.8% (95% CI: 26.6–37.6%) when
PCR-, hybridization-, PCR-hybridization-, and TMA-
based methods were used, respectively, and the differ-
ence was statistically significant (P = 0.02). Table 2 pre-
sents more detailed information on the prevalence of
HPV infection among FSWs for subgroups. The geo-
graphical distribution of HPV infection among FSWs is
shown in global maps in Fig. 3.
Genotype distribution of genital HPV infection in FSWs
Overall, fifty-two HPV types were detected among
FSWs across studies. The five most common high-
risk HPV types identified were HPV-16 (10.1, 95% CI:
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Fig. 1 Flowchart presenting the steps of literature search and selection
Farahmand et al. BMC Public Health         (2020) 20:1455 Page 5 of 14
Table 1 The characteristics of all eligible studies in this systematic review and meta-analysis
Author [Ref.] Publication Year Study location Total sample size No. HPV positive
Velazquez-Hernandez [41] 2019 Mexico 217 12
Diop-Ndiaye [42] 2019 Senegal 436 348
Ferre [43] 2019 Togo 310 140
Lockhart [44] 2019 Kenya 344 97
Adams [14] 2019 Ghana 100 26
Shahesmaeili [45] 2018 Iran 1318 552
Muñoz-Ramírez [46] 2018 Mexico 105 6
Hooi [29] 2018 Curaçao 76 19
Richards [47] 2018 Dominican Republic 143 62
Bui [48] 2018 Cambodia 200 94
Cameron [49] 2018 Kenya 330 97
Nasirian [50] 2017 Iran 99 7
Marra [51] 2017 Netherlands 304 238
Vorsters [52] 2016 Belgium 1334 556
Menon [53] 2016 Kenya 616 357
Singh [54] 2016 India 120 33
Leaungwutiwong [55] 2015 Thailand 100 13
Jia [28] 2015 China 309 191
Gomih-Alakija [56] 2014 Kenya 349 103
Aho [57] 2014 Guinea 223 27
Wang [58] 2013 China 288 192
Patel [59] 2013 Kenya 296 195
Marek [60] 2013 Hungary 34 28
Hoang [61] 2013 Vietnam 281 139
Ersan [24] 2013 Turkey 239 48
Yin [62] 2013 China 802 309
Keten [63] 2013 Turkey 137 53
Li [64] 2012 China 810 315
Ghosh [65] 2012 India 45 35
Couture [66] 2012 Cambodia 220 90
Brown [67] 2012 Peru 199 133
Shikova [68] 2011 Bulgaria 106 46
Matsushita [69] 2011 Japan 196 103
Dal Pogetto [70] 2011 Brazil 102 46
Znazen [71] 2010 Tunisia 188 83
Smith [72] 2010 Madagascar 90 33
Luchters [73] 2010 Kenya 776 429
Rhee [74] 2010 South Korea 2308 939
Valle’s [26] 2009 Guatemala 297 200
Miyashita [75] 2009 Philippines 369 211
del Amo [76] 2009 Spain 549 169
Sultana [77] 2008 Bangladesh 293 222
Sarkar [78] 2008 India 229 58
Hernandez [79] 2008 Vietnam 282 239
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8.2–12.5%), HPV-52 (7.9, 95% CI: 5.9–10.7%), HPV-53
(6.0, 95% CI: 4.4–8.1%), HPV-18 (5.4, 95% CI: 4.4–
6.8%) and HPV-58 (5.6, 95% CI: 4.2–7.3%). HPV-89
(7.0, 95% CI: 4.2–11.5%), HPV-50 (4.1, 95% CI: 2.2–
7.6%), HPV-6 (3.6, 95% CI: 2.8–4.6%), HPV-54 (3.4,
95% CI: 2.5–4.5%), and HPV-71 (3.3, 95% CI: 1.9–
5.8%) were also the most common low-risk HPV
types identified among FSWs (Fig. 4).
Discussion
Sexual intercourse is the main route of transmission
of HPV infection, which is known as one of the most
common infections around the world. According to
this view, FSWs are amongst the most vulnerable
group to acquire HPV infection and consequently, to
develop precursors of cervical cancer. In part, this
arises from the fact that they are constantly being ex-
posed to a large number of risk factors facilitating the
spread of sexually transmitted diseases [30]. Previous
studies among the general population have reported
that the prevalence of HPV ranged from 9 to 13% in
the world [98]. As expected, our findings indicated
that the number of HPV-positive cases is significantly
higher among FSWs compared to the general popula-
tion, and the prevalence varied from 13 to 82% across
the world.
Concerning the overall prevalence and genotype dis-
tribution of cervical HPV infection among FSWs, to
date, only one meta-analysis has been published by
Peng et al. in 2012, which was conducted on 4198
FSWs from nine Asian countries [31]. Their study
found a high HPV prevalence in different regions of
Asia, so that the overall HPV prevalence in East,
South-east, and South Asia were 49.6, 42.9, and
29.3%, respectively. Consistent with this, the results of
our meta-analysis also indicated that FSWs in most
Asian countries, like Bangladesh, China, Cambodia,
India, Japan, Philippines, South Korea, and Vietnam
had a prevalence of HPV infection greater than 40%.
The wide range of variations between the different
studies can be attributed to differences in the socio-
demographic and behavioral characteristics of FSWs.
As an example, we found that Mexican FSWs exhibit
low levels of HPV infection. It may be related to the
implementation of preventive programs such as pri-
mary cervical cancer screening, condom promotion,
and HPV vaccination, which were effective to reduce
the prevalence of HPV infection [41]. The application
of vaccines against HPV infection in 11-year-old girls
is a part of Mexico’s national immunization program
[46]. Previous studies showed that registered FSWs
are more likely to engage in screening and prevention
programs and more likely to use condoms than clan-
destine FSWs [99, 100]. Regarding the sex work en-
vironment, previous reports indicated that street-
based FSWs are at a higher risk for STIs compared
to other types of FSWs, mainly due to their social
status and engaging in sex work in an extremely
Table 1 The characteristics of all eligible studies in this systematic review and meta-analysis (Continued)
Author [Ref.] Publication Year Study location Total sample size No. HPV positive
Yun [80] 2008 South Korea 188 157
Gazi [81] 2008 Turkey 124 12
Didelot-Rousseau [82] 2006 Burkina Faso 360 238
Chandeying [83] 2006 Thailand 524 120
De Marco [84] 2006 Tunisia 64 28
del Amo [85] 2005 Spain 734 283
Canadas [86] 2004 Spain 187 52
Baay [87] 2004 Belgium 61 19
Mak [88] 2004 Belgium 99 72
Tideman [89] 2003 Australia 288 91
Choi [90] 2003 South Korea 417 194
Juarez-Figueroa [91] 2001 Mexico 495 242
Chan [92] 2001 Singapore 187 27
Kjaer [93] 2000 Denmark 182 59
Ishi [94] 2000 Japan 546 307
Langley [95] 1996 Senegal 681 293
Van Doornum [96] 1993 Netherlands 121 21
Kreiss [97] 1992 Kenya 198 66
NR Not reported
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Fig. 2 Forest plot of the prevalence of HPV infection in FSWs, stratified by study year (before and after 2010)
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unsafe workplace [101, 102]. However, as a limitation,
data regarding the sexual behaviors, sex work envi-
ronments, or type of sex worker did not include in
our meta-analysis.
Our results showed that HPV-16 and HPV-52 are
the most commonly identified genotypes in FSWs.
HPV-16 is considered as the most prominent type in-
volved in the development of cervical cancer and
other HPV-associated malignancies. HPV-52 is also
an oncogenic HPV type, which is closely related
phylogenetically to HPV-16. Previous studies have
shown that HPV-52 is the sixth most frequently de-
tected HPV high-risk type in CIN3 and invasive cer-
vical cancer [103].
Similar to Asian countries, the prevalence of HPV
positivity was significantly high among European
FSWs. Despite high coverage HPV vaccination
among females in Europe, our meta-analysis indi-
cated that HPV infection is very common among
FSWs in the Netherlands, Belgium, Bulgaria,
Denmark, Hungary, and Spain, with a prevalence of
HPV infection between 30 and 80%. Our explanation
is that vaccination does not protect against HPV
types other than 6, 11, 16, and 18. For instance, the
majority of FSWs in the Netherlands were infected
with types different than what was covered by the
current vaccines [51]. To overcome this problem, we
recommend the use of a nine-valent vaccine (9vHPV)
instead of the bivalent and quadrivalent vaccines. The
9vHPV vaccine contains type 6, 11, 16, 18, 31, 33, 45,
52, and 58 which was approved by the FDA in De-
cember 2014, and by the European Medicines Agency
(EMA) in June 2015 [104].
Based on the results of the study, we found that the
variations in the prevalence of HPV infection in
FSWs across the studies could not be explained by
the difference in detection methods. This is due to
that the detection rates were similar for HPV using
PCR, hybridization, and PCR-hybridization, which
were applied in 56 (93.3%) studies. However, sample
type may be one of the factors leading to differences
in prevalence rates. To confirm this finding, our
meta-analysis demonstrated that the detection rate of
HPV using vaginal samples was significantly higher
than cervical, endocervical, and cervico-vaginal sam-
ples. We concluded that the vaginal sample is more
sensitive for detecting HPV and has a higher level of
HPV DNA than the other genital specimens in FSWs.
Furthermore, vaginal sampling is a less invasive
method and is easily available for all women at the
time of a regular HPV test. Owing to the high preva-
lence of HPV in vaginal samples, vaginal douching
with disinfectants after sex with clients seemed to be
an effective practice in the reduction of HPV
transmission.
In some countries, such as Thailand, Singapore, and
Iran, the HPV prevalence is unexpectedly low, and we
believe that this is due to several reasons, like limited
Table 2 Subgroup analysis of the prevalence of HPV infection in female sex workers







Overall 61 42.6 (38.5–46.7) 96.9%, P < 0.0001
Diagnostic method PCR 46 43.2 (37.8–48.8) 97.0%, P < 0.01 P = 0.02†
Hybridization 7 41.4 (32.4–51.1) 96.2%, P < 0.01
PCR-Hybridization 3 40.9 (37.7–44.2) 58.4%, P = 0.09
TMA 4 31.8 (26.6–37.6) 75.0%, P < 0.01
Sample type Cervical 50 41.9 (37.6–46.4) 96.6%, P < 0.01 P = 0.04†
Endocervical 4 31.1 (21.1–43.4) 92.1%, P < 0.01
Vaginal 3 68.4 (37.7–88.5) 99.2%, P < 0.01
Cervico-vaginal 2 46.2 (40.2–52.2) 0%, P = 0.65
Diagnostic index L1 gene 26 45.1 (38.0–52.3) 96.9%, P < 0.01 P < 0.0001†
E6/E7 mRNA transcripts 4 31.8 (26.6–37.6) 75.0%, P < 0.01
E6 gene 1 75.7 (70.5–80.3) NA, NA
E6/E7 genes 1 26.0 (18.3–35.4) NA, NA
Study year 1992–2009 24 43.6 (36.1–51.4) 97%, P < 0.01 P = 0.71
2010–2019 37 41.9 (37.2–46.8) 97%, P < 0.01
NA Not applicable, PCR Polymerase chain reaction, TMA Transcription-mediated amplification;
† Statistically significant
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HPV screening practices, low socioeconomic status,
the illegality of sex work, severely limited support sys-
tems, unsafe workplaces, fear of stigmatization, and
lack of education or skills. Thus, it is so likely that
the obtained results in our meta-analysis may not be
a precise estimate of the HPV prevalence in these
regions.
The present study has some limitations that need to
be considered during the interpretation of our results.
First, a significant part of the studies investigating the
HPV prevalence among FSWs did not perform analysis
of HPV genotype distribution, and thus we could not
include their results in our meta-analysis of the genotype
distribution of HPV. Second, despite the subgroup ana-
lyses, significant heterogeneity still existed, suggesting
that it arises from other sources that we could not
characterize. Finally, there were no published data on
the prevalence of HPV infection among FSWs in so
many countries such as the United States, Canada,
Russia, France, Germany, Italy, the United Kingdom,
Nigeria, South Africa, Cameroon, and the Arabian
Peninsula.
The HPV vaccination is of public health importance,
and since 2009, the World Health Organization (WHO)
Fig. 3 The global maps are presenting the geographical variations in the prevalence of HPV infection in FSWs. Colors indicate the level of
prevalence of HPV infection per country
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has recommended the HPV vaccination as a prevent-
ive measure against cervical cancer with a primary
target population of girls aged 9 to 14 years. As of
mid-2019, however, HPV vaccines have been intro-
duced only in 93 countries [105], and many coun-
tries still have not implemented national HPV
vaccination programs. Governments should consider
that HPV vaccination is a cost-effective intervention
for the prevention of cervical cancer. Low socioeco-
nomic conditions such as poverty, poor income, and
low education levels are often regarded as the main
reasons for the involvement of women in sex work.
FSWs are a marginalized and stigmatized population
across the world and are highly vulnerable to various
forms of violence. Previous studies have indicated
that the risk of acquiring STIs among FSWs who
have experienced violence is nearly three times
greater compared to FSWs who have not experi-
enced violence [106]. Criminalization of sex work is
associated with more social stigma and increased
vulnerability of FSWs to violence [107]. Comprehen-
sive efforts should be directed and prioritized toward
reducing violence against this vulnerable population
as the vital preventive measures of STIs such as
HPV infection.
Conclusions
In summary, FSWs are a neglected population
around the world with a high prevalence of HPV in-
fection, deserving greater attention. Our findings
showed that high-risk HPV types are common
among FSWs. Persistent infection with high-risk
HPV types is the strongest risk factor for the devel-
opment of cervical intraepithelial neoplasia and cer-
vical or vaginal cancers. Besides, they can transmit
their infection to their male clients, which leads to a
high HPV prevalence and incidence of HPV-
associated malignancies among the general popula-
tion. Therefore, public health interventions, such as
the implementation of national HPV vaccination
strategies (particularly by 9vHPV vaccine), regular
screening of FSWs for HPV, and encouraging safer-
sex strategies like condom use are critical.
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